Invention Grant
- Patent Title: Methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD)
-
Application No.: US14436121Application Date: 2013-10-17
-
Publication No.: US10004780B2Publication Date: 2018-06-26
- Inventor: Thierry Leveillard , Jose-Alain Sahel , Therese Cronin , Leah Byrne , Ram Fridlich
- Applicant: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Applicant Address: FR Paris FR Paris
- Assignee: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE),CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Current Assignee: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE),CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
- Current Assignee Address: FR Paris FR Paris
- Agency: Whitham, Curtis & Cook
- Priority: EP12306278 20121017
- International Application: PCT/EP2013/071728 WO 20131017
- International Announcement: WO2014/060517 WO 20140424
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07K14/47 ; A61K38/17 ; A61K9/00 ; C12N9/02
Abstract:
The present invention relates to methods and pharmaceutical compositions for the treatment of age-related macular degeneration (AMD). In particular the present invention relates to RdCVFL polypeptide or polynucleotide for use in the treatment of AMD.
Public/Granted literature
- US20150265676A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION (AMD) Public/Granted day:2015-09-24
Information query
